Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1995 1
1996 4
1997 2
1998 6
1999 7
2000 7
2001 4
2002 5
2003 6
2004 4
2005 10
2006 9
2007 11
2008 8
2010 6
2011 4
2012 5
2013 11
2014 9
2015 6
2016 3
2017 7
2018 4
2019 4
2020 6
2021 10
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

150 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.
Diaz-Manera J, Kishnani PS, Kushlaf H, Ladha S, Mozaffar T, Straub V, Toscano A, van der Ploeg AT, Berger KI, Clemens PR, Chien YH, Day JW, Illarioshkin S, Roberts M, Attarian S, Borges JL, Bouhour F, Choi YC, Erdem-Ozdamar S, Goker-Alpan O, Kostera-Pruszczyk A, Haack KA, Hug C, Huynh-Ba O, Johnson J, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Diaz-Manera J, et al. Lancet Neurol. 2021 Dec;20(12):1012-1026. doi: 10.1016/S1474-4422(21)00241-6. Lancet Neurol. 2021. PMID: 34800399 Clinical Trial.
Bi-allelic truncating mutations in VWA1 cause neuromyopathy.
Deschauer M, Hengel H, Rupprich K, Kreiß M, Schlotter-Weigel B, Grimmel M, Admard J, Schneider I, Alhaddad B, Gazou A, Sturm M, Vorgerd M, Balousha G, Balousha O, Falna M, Kirschke JS, Kornblum C, Jordan B, Kraya T, Strom TM, Weis J, Schöls L, Schara U, Zierz S, Riess O, Meitinger T, Haack TB. Deschauer M, et al. Among authors: vorgerd m. Brain. 2021 Mar 3;144(2):574-583. doi: 10.1093/brain/awaa418. Brain. 2021. PMID: 33459760
FLNC-Associated Myofibrillar Myopathy: New Clinical, Functional, and Proteomic Data.
Kley RA, Leber Y, Schrank B, Zhuge H, Orfanos Z, Kostan J, Onipe A, Sellung D, Güttsches AK, Eggers B, Jacobsen F, Kress W, Marcus K, Djinovic-Carugo K, van der Ven PFM, Fürst DO, Vorgerd M. Kley RA, et al. Among authors: vorgerd m. Neurol Genet. 2021 May 18;7(3):e590. doi: 10.1212/NXG.0000000000000590. eCollection 2021 Jun. Neurol Genet. 2021. PMID: 34235269 Free PMC article.
Creatine for treating muscle disorders.
Kley RA, Tarnopolsky MA, Vorgerd M. Kley RA, et al. Among authors: vorgerd m. Cochrane Database Syst Rev. 2013 Jun 5;2013(6):CD004760. doi: 10.1002/14651858.CD004760.pub4. Cochrane Database Syst Rev. 2013. PMID: 23740606 Free PMC article. Review.
Methods to Study the Myenteric Plexus of Rat Small Intestine.
Hecking I, Stegemann LN, Stahlke S, Theis V, Vorgerd M, Matschke V, Theiss C. Hecking I, et al. Among authors: vorgerd m. Cell Mol Neurobiol. 2021 Dec 21. doi: 10.1007/s10571-021-01181-5. Online ahead of print. Cell Mol Neurobiol. 2021. PMID: 34932174
Creatine for treating muscle disorders.
Kley RA, Tarnopolsky MA, Vorgerd M. Kley RA, et al. Among authors: vorgerd m. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD004760. doi: 10.1002/14651858.CD004760.pub3. Cochrane Database Syst Rev. 2011. PMID: 21328269 Updated. Review.
Creatine for treating muscle disorders.
Kley RA, Vorgerd M, Tarnopolsky MA. Kley RA, et al. Among authors: vorgerd m. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004760. doi: 10.1002/14651858.CD004760.pub2. Cochrane Database Syst Rev. 2007. PMID: 17253521 Updated. Review.
150 results